For example, in pancreatic cancer, inhibiting the expression of NR3C2 leads to the upregulation of glycolytic enzymes HK1, HK2, and LDHA [17], promotes glucose uptake and lactate production and accelerates tumor growth. This evidence concerns the gene HK1 and familial pancreatic carcinoma.